GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IQVIA Holdings Inc (NYSE:IQV) » Definitions » Cyclically Adjusted PB Ratio

IQVIA Holdings (IQVIA Holdings) Cyclically Adjusted PB Ratio : 9.15 (As of Apr. 27, 2024)


View and export this data going back to 2013. Start your Free Trial

What is IQVIA Holdings Cyclically Adjusted PB Ratio?

As of today (2024-04-27), IQVIA Holdings's current share price is $234.88. IQVIA Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $25.66. IQVIA Holdings's Cyclically Adjusted PB Ratio for today is 9.15.

The historical rank and industry rank for IQVIA Holdings's Cyclically Adjusted PB Ratio or its related term are showing as below:

IQV' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 7.28   Med: 10.57   Max: 16.99
Current: 9.12

During the past years, IQVIA Holdings's highest Cyclically Adjusted PB Ratio was 16.99. The lowest was 7.28. And the median was 10.57.

IQV's Cyclically Adjusted PB Ratio is ranked worse than
90.84% of 131 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.98 vs IQV: 9.12

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

IQVIA Holdings's adjusted book value per share data for the three months ended in Dec. 2023 was $33.675. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $25.66 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


IQVIA Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for IQVIA Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IQVIA Holdings Cyclically Adjusted PB Ratio Chart

IQVIA Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 15.90 9.84 9.02

IQVIA Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.84 8.91 9.55 7.96 9.02

Competitive Comparison of IQVIA Holdings's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, IQVIA Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Cyclically Adjusted PB Ratio falls into.



IQVIA Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

IQVIA Holdings's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=234.88/25.66
=9.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, IQVIA Holdings's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=33.675/129.4194*129.4194
=33.675

Current CPI (Dec. 2023) = 129.4194.

IQVIA Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201403 -4.302 99.695 -5.585
201406 -4.890 100.560 -6.293
201409 -4.199 100.428 -5.411
201412 -5.672 99.070 -7.410
201503 -4.901 99.621 -6.367
201506 -5.722 100.684 -7.355
201509 -3.299 100.392 -4.253
201512 -4.724 99.792 -6.126
201603 -3.635 100.470 -4.682
201606 -3.868 101.688 -4.923
201609 -2.625 101.861 -3.335
201612 36.674 101.863 46.595
201703 34.461 102.862 43.358
201706 34.838 103.349 43.626
201709 30.741 104.136 38.205
201712 38.419 104.011 47.804
201803 39.461 105.290 48.505
201806 36.365 106.317 44.267
201809 35.665 106.507 43.338
201812 33.995 105.998 41.507
201903 33.545 107.251 40.479
201906 33.315 108.070 39.897
201909 31.603 108.329 37.756
201912 31.217 108.420 37.263
202003 29.016 108.902 34.483
202006 29.226 108.767 34.775
202009 30.496 109.815 35.940
202012 31.386 109.897 36.962
202103 31.070 111.754 35.981
202106 30.063 114.631 33.941
202109 30.502 115.734 34.109
202112 31.700 117.630 34.877
202203 31.268 121.301 33.361
202206 28.682 125.017 29.692
202209 28.778 125.227 29.742
202212 31.045 125.222 32.086
202303 31.978 127.348 32.498
202306 31.393 128.729 31.561
202309 31.808 129.860 31.700
202312 33.675 129.419 33.675

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


IQVIA Holdings  (NYSE:IQV) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


IQVIA Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of IQVIA Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


IQVIA Holdings (IQVIA Holdings) Business Description

Traded in Other Exchanges
Address
2400 Ellis Road, Durham, NC, USA, 27703
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Executives
Kevin C Knightly officer: Pres Info & Tech Solutions 1499 POST ROAD, FAIRFIELD CT 06824
Panagos Constantinos officer: See Remarks 4280 EMPEROR BLVD, DURHAM NC 27703
Eric Sherbet officer: See Remarks 100 IMS DRIVE, PARSIPPANY NJ 07054-4235
Keriann Cherofsky officer: See Remarks 4280 EMPEROR BLVD, DURHAM NC 27703
Sheila A Stamps director C/O CIT GROUP, 1 CIT DRIVE, ATTN: GENERAL COUNSEL, LIVINGSTON NJ 07039
Morris Leslie Wims director 4280 EMPEROR BLVD, DURHAM NC 27703
John Connaughton director, 10 percent owner BAIN CAPITAL PARTNERS LLC, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Ronald E Bruehlman officer: See Remarks C/O IQVIA HOLDINGS, INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
Ronald A Rittenmeyer director 5400 LEGACY DRIVE, PLANO TX 75024
Ari Bousbib director, officer: Chairman, CEO & Pres UNITED TECHNOLOGIES CORP, ONE FINANCIAL PLAZA, HARTFORD CT 06101
W Richard Staub officer: See Remarks
Tpg Group Holdings (sbs) Advisors, Inc. 10 percent owner C/O TPG GLOBAL, LLC, 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102
Michael J Evanisko director BRAUN CONSULTING, 20 W KINZIE STREET SUITE 1600, CHICAGO IL 60610
Michael R Mcdonnell officer: Chief Financial Officer C/O IQVIA HOLDINGS INC., 83 WOOSTER HEIGHTS ROAD, DANBURY CT 06810
John M. Leonard director C/O INTELLIA THERAPEUTICS INC, 40 ERIE STREET, SUITE 130, CAMBRIDGE MA 02139

IQVIA Holdings (IQVIA Holdings) Headlines

From GuruFocus

IQVIA Holdings Inc. - Special Call Transcript

By GuruFocus Research 01-23-2024

Q1 2023 IQVIA Holdings Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2022 IQVIA Holdings Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2021 IQVIA Holdings Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q4 2021 IQVIA Holdings Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

IQVIA Holdings Inc. - Special Call Transcript

By GuruFocus Research 01-23-2024

Q3 2020 IQVIA Holdings Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2023 IQVIA Holdings Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024